Using Shuotongo ureteroscopy to treat upper urinary tract stones
Clinical Study on the Treatment of Upper Urinary Tract Stones by Shuotong Scope
This study tests if a new method called Shuotongo ureteroscopy can safely and effectively remove larger kidney stones better than the usual techniques.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Handan First Hospital Academic / other |
| Locations | 1 site (Handan, Hebei) |
| Trial ID | NCT05712785 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of Shuotongo ureteroscopy for the surgical treatment of upper urinary tract stones. The procedure allows for simultaneous lithotripsy and stone removal, enhancing the stone discharge rate and improving overall outcomes. By utilizing a non-invasive approach through the natural lumen, the Shuotongo ureteroscopy offers a safer and repeatable option for patients, particularly those with larger stones. The study will assess the advantages of this technique compared to traditional ureteroscopy methods.
Who should consider this trial
Good fit: Ideal candidates for this study are patients clinically diagnosed with ureteral calculus who can cooperate with the treatment.
Not a fit: Patients with severe urinary tract infections or other conditions deemed unsuitable by investigators will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve stone removal rates and reduce the likelihood of stone recurrence in patients.
How similar studies have performed: While the Shuotongo ureteroscopy is a novel approach, similar ureteroscopy techniques have shown promise in improving stone removal outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of Ureteral calculus Must be able to cooperate with the treatment Exclusion Criteria: * Patients had severe urinary tract infections; patients had other conditions which investigators thought not suitable for the study.
Where this trial is running
Handan, Hebei
- Kunwu Yan — Handan, Hebei, China (Recruiting)
Study contacts
- Principal investigator: kunwu yan, Master — Handan First Hospital
- Study coordinator: kunwu yan, Master
- Email: 1749200794@qq.com
- Phone: +8618232053937
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.